Mineralys Therapeutics (MLYS) Selling, General & Administrative (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 647.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -1.52 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 20.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.98 Mn |
| Dec 31, 2025 | 13.88 Mn |
| Sep 30, 2025 | 9.68 Mn |
| Jun 30, 2025 | 8.47 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 5.90 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | 3.85 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 884,000.00 |
| Mar 31, 2022 | 791,000.00 |